Bluejay Diagnostics Inc
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnos… Read more
Bluejay Diagnostics Inc (BJDX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.243x
Based on the latest financial reports, Bluejay Diagnostics Inc (BJDX) has a cash flow conversion efficiency ratio of -0.243x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.45 Million) by net assets ($5.98 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bluejay Diagnostics Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Bluejay Diagnostics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bluejay Diagnostics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bluejay Diagnostics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mobile Global Esports Inc.
NASDAQ:MGAM
|
-1.427x |
|
Michman Basad Ltd
TA:MCMN
|
-0.271x |
|
Go Green Global Tech
OTCQB:GOGR
|
0.000x |
|
Getty Copper Inc
PINK:GTCDF
|
-0.010x |
|
SIMPSON MANUFACTRNG
MU:TWL
|
0.063x |
|
MITSUI MNG & SMLT
DU:MMG
|
N/A |
|
Eduform'action S.A.
PA:MLEFA
|
N/A |
|
Bless Asset Group PCL
BK:BLESS
|
0.018x |
Annual Cash Flow Conversion Efficiency for Bluejay Diagnostics Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Bluejay Diagnostics Inc from 2019 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $5.98 Million | $-6.05 Million | -1.013x | +25.77% |
| 2024-12-31 | $5.73 Million | $-7.82 Million | -1.365x | +52.48% |
| 2023-12-31 | $2.89 Million | $-8.31 Million | -2.872x | -328.15% |
| 2022-12-31 | $11.54 Million | $-7.74 Million | -0.671x | -213.08% |
| 2021-12-31 | $20.38 Million | $-4.37 Million | -0.214x | -277.15% |
| 2020-12-31 | $-4.21 Million | $-508.71K | 0.121x | -79.02% |
| 2019-12-31 | $-2.93 Million | $-1.69 Million | 0.576x | -- |